|
Summary
2005, Vol. 17, No. 1, Pages 1-14
The Biopersistence of Canadian Chrysotile Asbestos Following Inhalation: Final Results Through 1 Year After Cessation of ExposureDavid M. BernsteinConsultant in Toxicology, Geneva, Switzerland Rogers Imaging Corporation, Needham, Massachusetts, USA Research & Consulting Company Ltd., Füllinsdorf, Switzerland Chrysotile asbestos, a serpentine mineral, has been shown to be notably different from amphibole asbestos such as amosite, crocidolite, and tremolite in that chrysotile once inhaled is rapidly removed from the lung while the amphiboles persist. This has been demonstrated for three different chrysotile samples from Canada, the United States, and Brazil. The initial results of the inhalation biopersistence study on the Canadian chrysotile were reported earlier. This article presents the full results through 365 days after cessation of exposure. In order to fully understand the dynamics of the clearance of chrysotile from the lung, the study included a standardised inhalation biopersistence study following the recommendations of the European Commission (EC) Interim Protocol for the Inhalation Biopersistence of synthetic mineral fibers (Bernstein & Riego-Sintes, 1999) in which the lungs were digested to evaluate fiber content remaining. In addition, confocal microscopy was used to examine lungs in three dimensions to determine where and what size the remaining fibers were in the lung tissue. The results showed that Canadian chrysotile is cleared from the lung with a clearance half-time of 11.4 days for the fibers longer than 20 μm. Canadian chrysotile clears in a range similar to that of glass and stone wools. It remains less biopersistent than ceramic and special purpose glasses and considerably less biopersistent than amphibole asbestos. At 1 yr after cessation of exposure, no long (L>20 μm) chrysotile fibers remained in the lung. In contrast, with amosite asbestos there were 4 × 105 long fibers (L>20 μm) remaining in the lungs at one year after cessation of exposure (Hesterberg et al., 1998). These results fully support the differentiation of chrysotile from amphiboles reported in recent evaluations of available epidemiological studies (Hodgson & Darnton, 2000; Berman & Crump, 2004). Forward Links to Citing ArticlesLloyd E. Stettler, Douglas D. Sharpnack, Edward F. Krieg. (2008) Chronic Inhalation of Short Asbestos: Lung Fiber Burdens and Histopathology for Monkeys Maintained for 11.5 Years after Exposure. Inhalation Toxicology 20:1, 63-73 Online publication date: 1-Jan-2008. Summary | Full Text | PDF (6944 KB) | PDF Plus (6718 KB) D. M. Bernstein, K. Donaldson, U. Decker, S. Gaering, P. Kunzendorf, J. Chevalier, S. E. Holm. (2008) A Biopersistence Study following Exposure to Chrysotile Asbestos Alone or in Combination with Fine Particles. Inhalation Toxicology 20:11, 1009-1028 Online publication date: 1-Jan-2008. Summary | Full Text | PDF (678 KB) | PDF Plus (727 KB) Charles M. Yarborough. (2006) Chrysotile as a Cause of Mesothelioma: An Assessment Based on Epidemiology. Critical Reviews in Toxicology 36:2, 165-187 Online publication date: 1-Jan-2006. Summary | Full Text | PDF (165 KB) | PDF Plus (273 KB) David M. Bernstein, Rick Rogers, Paul Smith, Jörg Chevalier. (2006) The Toxicological Response of Brazilian Chrysotile Asbestos: A Multidose Subchronic 90-Day Inhalation Toxicology Study with 92-Day Recovery to Assess Cellular and Pathological Response. Inhalation Toxicology 18:5, 313-332 Online publication date: 1-Jan-2006. Summary | Full Text | PDF (1289 KB) | PDF Plus (1321 KB) David M. Bernstein, Jörg Chevalier, Paul Smith. (2005) Comparison of Calidria Chrysotile Asbestos to Pure Tremolite: Final Results of the Inhalation Biopersistence and Histopathology Examination Following Short-Term Exposure. Inhalation Toxicology 17:9, 427-449 Online publication date: 1-Jan-2005. Summary | Full Text | PDF (2365 KB) | PDF Plus (2362 KB) |
|





TOC Alert